Preliminary Evaluation of the Effect of Investigational Ebola Virus Disease Treatments on Viral Genome Sequences

The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus

(2016) Laura K. McMullan et al.   ANTIVIRAL RESEARCH

Clinical Management of Ebola Virus Disease in the United States and Europe

(2016) Timothy M. Uyeki et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States

(2015) Allison M. Liddell et al.   ANNALS OF INTERNAL MEDICINE

Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone

(2015) Daniel J. Park et al.   CELL

Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease

(2015) Diana F. Florescu et al.   CLINICAL INFECTIOUS DISEASES

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States

(2015) Colleen S. Kraft et al.   CLINICAL INFECTIOUS DISEASES

Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa

(2015) Miles W. Carroll et al.   NATURE

Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone

(2015) Yi-Gang Tong et al.   NATURE

Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

(2015) Emily P. Thi et al.   NATURE

Mutation rate and genotype variation of Ebola virus from Mali case sequences

(2015) T. Hoenen et al.   SCIENCE

Evaluation of the Potential Impact of Ebola Virus Genomic Drift on the Efficacy of Sequence-Based Candidate Therapeutics

(2015) Jeffrey R. Kugelman et al.   mBio

Inhibition of Hepatitis C Virus in Chimeric Mice by Short Synthetic Hairpin RNAs: Sequence Analysis of Surviving Virus Shows Added Selective Pressure of Combination Therapy

(2014) A. Dallas et al.   JOURNAL OF VIROLOGY

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

(2014) Xiangguo Qiu et al.   NATURE

Emergence of Zaire Ebola Virus Disease in Guinea

(2014) Sylvain Baize et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Care of Two Patients with Ebola Virus Disease in the United States

(2014) G. Marshall Lyon et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia

(2014) Benno Kreuels et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak

(2014) S. K. Gire et al.   SCIENCE

Nomenclature- and Database-Compatible Names for the Two Ebola Virus Variants that Emerged in Guinea and the Democratic Republic of the Congo in 2014

(2014) Jens Kuhn et al.   Viruses-Basel

Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus

(2014) Jonathan Audet et al.   Scientific Reports

Ebola and travel – Management of imported cases

(2014) Philippe Brouqui et al.   Travel Medicine and Infectious Disease

Selection and Recombinant Phenotyping of a Novel CMX001 and Cidofovir Resistance Mutation in Human Cytomegalovirus

(2013) Scott H. James et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses

(2012) Wendy Painter et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Evolution of Viruses of the Family Filoviridae Based on 97 Whole-Genome Sequences

(2012) S. A. Carroll et al.   JOURNAL OF VIROLOGY

Performance comparison of benchtop high-throughput sequencing platforms

(2012) Nicholas J Loman et al.   NATURE BIOTECHNOLOGY

Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies

(2012) X. Qiu et al.   Science Translational Medicine

Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies

(2011) Xiangguo Qiu et al.   CLINICAL IMMUNOLOGY

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

(2010) Thomas W Geisbert et al.   LANCET

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art

(2009) Karl Y. Hostetler   ANTIVIRAL RESEARCH